FINDEX Inc.
Vision for 2025

5 th July 2021
FINDEX. Inc
🄫2021 FINDEX Inc.

Introduction – Who We Are
On March 23, 2011, right after the Great East Japan Earthquake, FINDEX was listed on JASDAQ.
After experiencing this catastrophe, we realized how difficult it is to live a healthy life,and for the past 10 years, we have sought ways to contribute to everyone's health.
Our mission is to accelerate our challenges in the medical field with valuable technologies, and to support thehealth of the people. We have developed and accumulated various new technologies through R&D together
with many university hospitals and national centers.
In 2021, our 10 th year since listed, the world is in the middle of Covid-19 crisis, and our social responsibility
has become even greater. FINDEX is already playing a significant role in supporting the healthcare of medical
institutions and their patients. We believe that it is our responsibility to thoroughly review our corporate
governance system and to ensure the stability and growth of our business in perpetuity.
By 2025, FINDEX is committed to establishing sales of own new product Gaze Analyzing Perimeter worldwide
and to completing conversions of all hospital information system packages from on-premises to cloud services.
Under the advanced networks and systems, each person receives equal medical services, detect diseases at
early stages, and lead a healthy life. Our goal is to realize such a society, and to contribute to the building of asustainable community.
In the coming years, FINDEX will use the technologies and knowledge accumulated through R&D to bring new
products and services to the market. With strategic alliances with other corporations and organizations,
FINDEX will also launch products and services worldwide, structuring new sales models and growing ourrevenue.
Enrich society with our refined technologies 2021-2025

🄫2021 FINDEX Inc.

（1）

Table of Contents

1. Our Vision3

2. Our Past and Future - Review and Planning

4-5

3. Key Strategies 2021-2025

6

4. Management Efficiency and Growth Strategies 2021-2025

7

5. Segment Strategies（Medical System / Office System / HealthTech）

8-13

6. Notes Regarding Forward-Looking Statements

14

🄫2021 FINDEX Inc.

（2）

Our Vision

We will contribute to build a society in which all people
around the world can lead healthy lives
Effective Useof ICT

Equitable HealthCare Services

2021-2025

2011-2020
Active investment inresearch and development• Acquisition of technology
and knowledge- Accumulation•MedicalSystems
Hospital
🄫2021 FINDEX Inc.

•Utilize our refinedtechnologies andknowledge through R&D

Early Detectionof Diseases

-2030
•

Enrich oursociety- Execution

OfficeSystems
Document/
Workflow

HealthTech
Personal/
Business（3）

Our Past - Review
Active investment in research and development and acquisition of technology
and knowledge 2011-2020(￥ Millions)

Initiatives over the past 10 years
2011～2020

2017*1●Establishing a de facto standard for hospital
information systems (HIS)

Sales●Advanced research and development of theentire medical system together withuniversity hospitals●Research and development of medicaldevices and its application to clinical dataanalysis●Development of DocuMakerOffice todevelop the non-medical market*Implementing functions for local
governments

2020

GrowthRate

3,311

4,004

20.9%

Ordinary Profit

547

643

17.6%

Ordinary Profit
Margin

16.5%

16.1%

-0.4%

ROE
(Return on Equity)

13.0%

14.0%

+1.0%

Research Progress
on GAP*2

40％

95％

Research progresson DMO*315％

95％（For local Governments）
🄫2021 FINDEX Inc.

*1 Consolidated in 2017,the table above the comparison of growth with the year ending December 2020,
which is four years after the start of consolidation.
*2 GAP: Gaze Analyzing Perimeter*3 DMO: DocuMakerOffice（4）

Our Future - Planning
Utilize our refined technologies and knowledge through R&D

Initiatives for the next five years:
2021～2025●Connecting medical data from eachhospital as a part of the collaborated
infrastructure●Development of technologies thatenable safe and effective use of patient
information●Establishing a global market with
innovative medical devices and datautilization●Building our presence as an innovative
software creators for local governments
and public corporations

by 2025
🄫2021 FINDEX Inc.

Management Targets (Consolidated)(￥ Millions)

12,00010,80010,000
8,500
8,000
7,000

5,600

6,000

4,900

4,600
3,400

4,000
2,400
2,000

Target:Shareholder payout ratio of 35%

2021-2025

1,600
1,010

0

FY2021
医療システムMedical System

FY2022

FY2023

Office System
非医療システムFY2024
HealthTech
ヘルステックFY2025
Operating Income
経常利益（5）

Key Strategies 2021-2025

Build a service supply chain to rapidly penetrate new markets
with competitive R&D assets across all business segments

MedicalSystems
HospitalOfficeSystems
Document/
Workflow

HealthTechPersonal/
Business
🄫2021 FINDEX Inc.

 Promptly roll out cloud-based hospital information systems to existing users andprovide a new billing model to small and mid-sized hospitals.
 Developing a "medical support cloud service" that connects hospitals with existing
systems and patients.
 Securely manage the accumulation of medical data in compliance with the Next
Generation Medical Infrastructure Act and the Personal Information Protection Act- Building a data business to support drug discovery and therapeutic development.
 Selectively devote all DocuMaker Office resources on local governments andpublic corporations.
 Invest maximum amount of marketing resources in " Approval and Document
Management Systems" to raise market awareness.
 Targeting early market leadership through multifaceted development with major
manufacturers having sales channels to local governments and mid-sized systemvendors having networks in each local area as partners.
 Invest 80% of R&D resources in GAP (Gaze Analyzing Perimeter) and expand
product value and sales channels by adding functions and localizing the productfor overseas markets.
 In addition to the early penetration into ophthalmic medical institutions via
domestic ophthalmic medical device dealers, we will create a new market for
medical examinations.
 Establish a market in EU, USA, ASEAN, CHINA, and INDIA by collaborating withcompanies having strong connections to overseas markets.
（6）Management Efficiency and Growth Strategies 2021-2025

Concentrate management resources and promote further R&D
Create new markets by hiring/promoting those who drive business efficiency and globalization

Concentration of Management Resources

Advanced R&D⚫ Reconceptualization of our presence as aR&D-oriented company⚫ Focus on key products in each businesssegment to improve product capabilities andbrand recognition⚫ Narrow down the number of ongoing direct
sales users and strengthen the partner sales
sector⚫ Proactively conduct joint research withindustry, academia and government todevelop innovative products⚫ Enhance the internal education system andpromote graduate schools and MBA
programs for employees.
⚫ Flexible transfer of employees from thesystem development division to the R&D unit

Management Optimization

HR Retention⚫ More Hiring at regional offices andconsolidating back-office operations⚫ Enable flexible staffing, including
management levels

🄫2021 FINDEX Inc.

⚫ Build a diverse workforce and actively
promote women to managerial positions⚫ Maximize the growth potential of employeesby allowing them to change divisions in a
flexible manner based on their preferences⚫ Efficiently open regional and overseas offices
to expand work possibilities and encourage
flexible work styles（7）

Business Strategies – Medical Systems 1/2

Realize a seamless society by linking external services associated withmedical services by utilizing our in-hospital information systems

Making telemedicine moreaccessible - Aiming for acommunity where people
receive high-quality medicalservices regardless of where
they are.

Digitalization in medical
institutions contributes toaddressing environmental
issues.

Contribution for
digitalizing prescriptions,smooth prescribing, andR&D on drug discovery.

Collaborating with various
infrastructures, frommaking appointments toselecting transportation
to/from hospitals.

FINDEX provides patient consultation support via cloud computing system.
Alliances with various companies to support hospitals and patient care cycles
🄫2021 FINDEX Inc.

（8）

Business Strategies – Medical Systems 2/2
This segment is the origin of FINDEX's strengthand maintains steady growth and stability
Targets for Medical System Sales(￥ Millions)●Based on our delivery record to
most university hospitals, steady
growth will be maintained in thefuture

8,000

7,000

6,900

6,000

●Stable profits from maintenancesupport as a stock business●With the launch of the cloudservice, the service will have aneven higher retention rate
●Use of medical data for thedevelopment of pharmaceuticals
and medical devices

5,800
5,200

5,0004,700
4,430

4,000

3,000

2,000

1,000

●Make the Medical Cloud Networka part of our lives

0
FY2021

🄫2021 FINDEX Inc.

FY2022

FY2023

FY2024FY2025

Hospital
Information System
病院情報システム

Maintenance
保守サポート Support

Consumer Services
ヘルステックサービス（子会社含む）(including subsidiaries)

Dataservices
データサービス（他社協業）(collaboration with other companies)（9）Segment Strategies – Office Systems 1/2
Document management systems with a proven track record in large hospitals Delivering great usability and reliability to a variety of industries
Provide one-stop service for approval process and document
management, which most of the mid/small sized municipalities
have been a hurdle for efficient and continuous operation.
Paperless and stamp less work environment leads tomore efficient day-to-day operations(telecommuting is also available)

Local Government Digital Transformation Promotion Plan (Jan. 2021 - Mar. 2026)
The Ministry of Internal Affairs and Communications (MIC) has allocated a budget of approximately 3.8 billion
yen for local government Digital Transformation (DX) in 2021
This is about five times more than the initial budget for 2020.
The government encourages electronic approval and paperless management of administrative documents

Actively promoting implementation and sales through partners
In addition to the medical field, which is experiencing stable growth,Make the business for local governments a segment with growth potential
🄫2021 FINDEX Inc.

（10）

Segment Strategies – Office Systems 2/2
Leveraging our experience in medical systems
to create a new market for municipalities and public corporations●Targeting medium-sized municipalities
and public corporations●Using Cloud to achieve effective system implementation(Reduction of implementation time& efficient management of human capital)●Strategic collaboration
with sales partners of leading manufacturers●The market environment is favorable with less competitionin this field, where systematization will proceed in the future●Since the platform is shared with the medical version,
it can be sold at a low price, but at the same time,it has a lot of experience in terms of functionality
and stability, so smooth implementation can be expected

Office System Sales Targets(￥ Millions)

700

600
600

500

400
400

300

200
200

100

7020

●Conduct effective marketing to increase market awareness

0FY2021

FY2022

FY2023

FY2024FY2025*Business Market
1,718 cities, towns and villages in Japan(Cities: 792 Towns: 743 Villages: 183)
Source: Ministry of Internal Affairs and Communications
🄫2021 FINDEX Inc.

（11）

Segment Strategies – HealthTech 1/2

Improve access to healthcare on a global scale and contribute to thedevelopment of preventive medicine through our unique and latest technology●Joint research with Kyoto University for over 5years - Implemented a new method for easy andquick perimetry●Completed medical device registration andearned positive reputations at both domestic andinternational conferences●Comparing to existing perimetry - Smaller andmore affordable, takes less time
⇨Boosts the number of screening and improves
early detection rate

GAP：Gaze Analyzing Perimetry
Medical Device Manufacturingand Sales Authorization
Number：38B2X10003000002●Aim to set a new standard of perimetry thatcan diagnose various diseases with a single test

FINDEX is the owner of the patent for technologies applied to GAPAiming to launch worldwide with competitive advantages
🄫2021 FINDEX Inc.

（12）

Segment Strategies – HealthTech 2/2●More partnerships with companies with domestic and global sales networks to accelerate our growth●Global rollout of innovative medical devices utilizing eye tracking data（Perimetry/Screening of early-​stage dementia）●Leveraging original data from our medical devices to launch business for drug discovery and treatment developments●Affordable, easy and quick perimetry – Boosts the number of screening and improves profitability of hospitals and clinics(￥ Millions)

GAP – Shipping Volume Index
3,500

4,000

3,000

3,500

GAP – Numerical Targets
3,300

3,000

2,500

2,500

2,250

2,000
2,000

1,600

1,500
1,500
1,000
1,000
500

820

500
15000
FY2021
Domestic
国内病院
Hospitals🄫2021 FINDEX Inc.

FY2022

FY2023
Overseas
海外

FY2024FY2025

Health Care Centers
検診
Community Clinics

FY2021
Domestic
国内病院
Hospitals

FY2022

FY2023

海外Overseas

FY2024FY2025

Health Care Centers
検診
Community Clinics（13）

Cautionary Statements Regarding Forward-Looking Statements

This material is provided for informational purposes only and does not constitute a solicitation of any action based on this material.
This document (including the business plan) has been prepared by the Company based on reliable information available at the time of preparation,
but it contains risks and uncertainties, and the Company assumes no responsibility for its accuracy or completeness. The Company assumes noresponsibility for the accuracy or completeness of the information contained in this material, even if it is desirable to update or revise forecasts orplans.
The Company assumes no responsibility whatsoever for any losses that may arise from investment decisions based on the forecasts and target
figures contained in this document.
The copyright of this material belongs to Findex Inc.
No part of this report may be reproduced or distributed in any form or by any means without the prior written permission of the Company.

🄫2021 FINDEX Inc.

（14）

🄫2021 FINDEX Inc.